Objective: This study was performed to compare the pharmacokinetics of methotrexate (MTX) in unruptured ectopic pregnancy according to the injection route. Methods: Between May 2005 and August 2009, thirty-five patients of unruptured ectopic pregnancy in Chungbuk National University Hospital were treated medically either by intramuscular (IM) or intraamniotic (IA) injection of MTX according to the presence of fetal heart beat. Serum concentration of MTX was measured by fluorescent immunoassay using the blood samples withdrawn serially after its injection. Results: The peak plasma MTX level was achieved at the 30-minute after injection sample in both groups. 
MTX 치료 후 혈청 β-hCG는 치료 성패나 투여 경로와 관계없이 빠른 속도로 감소하였다 (Fig. 3) . 
MTX 투여에 따른 부작용

